Dr. Gomella Featured in OncLive Video about Androgen-Deprivation Therapy
Leonard Gomella, MD, chair of the Department of Urology at Jefferson, is featured in an OncLive video about the minimum testosterone level achieved by androgen-deprivation therapy (ADT) for men with advanced prostate cancer.
Recent data suggests that testosterone levels should be below 20 ng/dL in order to achieve the best results. This level of testosterone is difficult to achieve using standard injectables. However, according to Dr. Gomella, newer ADT agents have been successful at decreasing testosterone levels below 20 ng/dL.
Watch the full "Dr. Gomella Discusses Androgen-Deprivation Therapy" video.
Publication: OncLive
Published: 1/12/2012